Chronic obstructive pulmonary disease (COPD) can rob us of certain physical abilities, possibly preventing us from doing some ...

A Phase 3 clinical trial testing benralizumab as a potential treatment in COPD patients has failed to meet its main goal.

Columnist Caroline Gainer experiences relentless fatigue, chills, and sweating, possibly from COPD and/or chronic ...

Note: This column describes the author’s own experiences with guaifenesin. Not everyone will have the same response to treatment. Consult your doctor before starting or stopping a therapy. We always ...

Arthritis often occurs with chronic obstructive pulmonary disease (COPD). For me, each moment of pain in my hips is another ding to my oxygen saturation, or at least that’s how it seems. I’ve been in ...

While watching coverage of a landslide on my news feed, I was reminded of a time when I had a close brush with one. A carpool I was in just missed it, but the carpool of friends behind us wasn’t so ...

Now that I have treatment for my depression and inability to sleep, I look a little differently than I used to at the occasions when I feel fatigued. I think it’s important for those of us with ...

Note: This column describes the author’s own experiences with the sleep aid and antidepressant trazodone. Not everyone will have the same response to treatment. Consult your doctor before starting or ...

The U.S. Food and Drug Administration (FDA) has approved Nucala (mepolizumab) as an add-on maintenance treatment for certain people with chronic obstructive pulmonary disease (COPD). The treatment, ...

Using e-cigarettes, often called vaping, significantly increases the risk of chronic obstructive pulmonary disease (COPD), a U.S. study suggests. People who used e-cigarettes, which are ...

The U.S. Food and Drug Administration (FDA) has approved Abrysvo, a vaccine that protects against lung infections caused by the respiratory syncytial virus — commonly known as RSV — for adults as ...

The U.S. Food and Drug Administration (FDA) has approved Dupixent (dupilumab) as an add-on maintenance treatment for adults with poorly controlled chronic obstructive pulmonary disease (COPD) and high ...